Novelty Nobility

Seongnam, South Korea · Founded 2017 · Privately Held (backing)

Operator of a biotech company intended to develop antibodies and antibody-drug conjugates to overcome drug resistance. Novelty Nobility is based in Seongnam, South Korea and was founded in 2017. Its last known valuation is $10.8 million. It has raised $60.8 million.

Last price · $/share
—
Implied valuation
$10.8M
Total raised
$60.8M
Last round
—
What is Novelty Nobility worth?
$10.8Mlast known valuation
Free account
More of Novelty Nobility with a free account
  • ·The complete investor list: 29 names
  • ·Watch Novelty Nobility: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Novelty Nobility funding history

No rounds on record

No funding rounds for Novelty Nobility are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Novelty Nobility valuation

Novelty Nobility's last known valuation is $10.8 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Novelty Nobility's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Novelty Nobility, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Novelty Nobility

What is Novelty Nobility worth?
Novelty Nobility's last known valuation is $10.8M.
How much has Novelty Nobility raised?
Novelty Nobility has raised $60.8M in total funding across its recorded rounds.